Cloning and characterization of the promoter of Hugl-2, the human homologue of Drosophila lethal giant larvae (lgl) polarity gene

Biochemical and Biophysical Research Communications

Volumn 366, Issue 4, 2008, Pages 1067-1073

  Zimmermann, Tim ^a   Kashyap, Anubha ^a   Hartmann, Urs ^a   Otto, Gerd ^a   Galle, Peter R ^a   Strand, Susanne ^a   Strand, Dennis ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

EGF; Hugl 2; lgl; Promoter study; Sp 1

Indexed keywords

ANIMAL CELL; ARTICLE; CELL LINE; CONSERVATION GENETICS; CONTROLLED STUDY; DROSOPHILA; EMBRYO; ENZYME ASSAY; GENE; GENE ACTIVATION; GENE ACTIVITY; GENE EXPRESSION; GENOME ANALYSIS; HUGL 2 GENE; HUMAN; HUMAN CELL; LETHAL GIANT LARVAE GENE; LIVER CELL; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN FUNCTION; SEQUENCE HOMOLOGY; TUMOR SUPPRESSOR GENE;

ANIMALS; BASE PAIRING; BASE SEQUENCE; CELL LINE; CELL POLARITY; CERCOPITHECUS AETHIOPS; CLONING, MOLECULAR; COS CELLS; CYTOSKELETAL PROTEINS; DOWN-REGULATION; DROSOPHILA MELANOGASTER; DROSOPHILA PROTEINS; EPIDERMAL GROWTH FACTOR; GENES, INSECT; HUMANS; MOLECULAR SEQUENCE DATA; PROMOTER REGIONS (GENETICS); SEQUENCE ALIGNMENT; SEQUENCE HOMOLOGY, AMINO ACID; SP1 TRANSCRIPTION FACTOR; TUMOR SUPPRESSOR PROTEINS;

EID: 37549016358     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2007.12.084     Document Type: Article

References (27)

1. Agrawal N., Kango M., Mishra A., and Sinha P. Neoplastic transformation and aberrant cell-cell interactions in genetic mosaics of lethal(2)giant larvae (lgl), a tumor suppressor gene of Drosophila. Dev. Biol. 172 (1995) 218-229
2. Woodhouse E., Hersperger E., Stetler-Stevenson W.G., Liotta L.A., and Shearn A. Increased type IV collagenase in lgl-induced invasive tumors of Drosophila. Cell Growth Differ. 5 (1994) 151-159
3. Woodhouse E., Hersperger E., and Shearn A. Growth, metastasis, and invasiveness of Drosophila tumors caused by mutations in specific tumor suppressor genes. Dev. Genes Evol. 207 (1998) 542-550
4. Strand D., Unger S., Corvi R., Hartenstein K., Schenkel H., Kalmes A., Merdes G., Neumann B., Krieg-Schneider F., Coy J.F., et al. A human homologue of the Drosophila tumour suppressor gene l(2)gl maps to 17p11.2-12 and codes for a cytoskeletal protein that associates with nonmuscle myosin II heavy chain. Oncogene 11 (1995) 291-301
5. Kagami M., Toh-e A., and Matsui Y. Sro7p, a Saccharomyces cerevisiae counterpart of the tumor suppressor l(2)gl protein, is related to myosins in function. Genetics 149 (1998) 1717-1727
6. Larsson K., Bohl F., Sjostrom I., Akhtar N., Strand D., Mechler B.M., Grabowski R., and Adler L. The Saccharomyces cerevisiae SOP1 and SOP2 genes, which act in cation homeostasis, can be functionally substituted by the Drosophila lethal(2)giant larvae tumor suppressor gene. J. Biol. Chem. 273 (1998) 33610-33618
7. Grifoni D., Garoia F., Schimanski C.C., Schmitz G., Laurenti E., Galle P.R., Pession A., Cavicchi S., and Strand D. The human protein Hugl-1 substitutes for Drosophila lethal giant larvae tumour suppressor function in vivo. Oncogene 23 (2004) 8688-8694
8. Ohshiro T., Yagami T., Zhang C., and Matsuzaki F. Role of cortical tumour-suppressor proteins in asymmetric division of Drosophila neuroblast. Nature 408 (2000) 593-596
9. Yamanaka T., Horikoshi Y., Sugiyama Y., Ishiyama C., Suzuki A., Hirose T., Iwamatsu A., Shinohara A., and Ohno S. Mammalian Lgl forms a protein complex with PAR-6 and aPKC independently of PAR-3 to regulate epithelial cell polarity. Curr. Biol. 13 (2003) 734-743
10. Betschinger J., Mechtler K., and Knoblich J.A. The Par complex directs asymmetric cell division by phosphorylating the cytoskeletal protein Lgl. Nature 422 (2003) 326-330
11. Plant P.J., Fawcett J.P., Lin D.C., Holdorf A.D., Binns K., Kulkarni S., and Pawson T. A polarity complex of mPar-6 and atypical PKC binds, phosphorylates and regulates mammalian Lgl. Nat. Cell Biol. 5 (2003) 301-308
12. Schimanski C.C., Schmitz G., Kashyap A., Bosserhoff A.K., Bataille F., Schafer S.C., Lehr H.A., Berger M.R., Galle P.R., Strand S., and Strand D. Reduced expression of Hugl-1, the human homologue of Drosophila tumour suppressor gene lgl, contributes to progression of colorectal cancer. Oncogene 24 (2005) 3100-3109
13. Kuphal S., Wallner S., Schimanski C.C., Bataille F., Hofer P., Strand S., Strand D., and Bosserhoff A.K. Expression of Hugl-1 is strongly reduced in malignant melanoma. Oncogene 25 (2006) 103-110
14. Sonawane M., Carpio Y., Geisler R., Schwarz H., Maischein H.M., and Nuesslein-Volhard C. Zebrafish penner/lethal giant larvae 2 functions in hemidesmosome formation, maintenance of cellular morphology and growth regulation in the developing basal epidermis. Development 132 (2005) 3255-3265
15. Yasumi M., Sakisaka T., Hoshino T., Kimura T., Sakamoto Y., Yamanaka T., Ohno S., and Takai Y. Direct binding of Lgl2 to LGN during mitosis and its requirement for normal cell division. J. Biol. Chem. 25 (2005) 6761-6765
16. Bialucha C.U., Ferber E.C., Pichaud F., Peak-Chew S.Y., and Fujita Y. p32 is a novel mammalian Lgl binding protein that enhances the activity of protein kinase Czeta and regulates cell polarity. J. Cell Biol. 178 (2007) 575-581
17. Galle P.R., Hagelstein J., Kommerell B., Volkmann M., Schranz P., and Zentgraf H. In vitro experimental infection of primary human hepatocytes with hepatitis B virus. Gastroenterology 106 (1994) 664-673
18. Cartharius K., Frech K., Grote K., Klocke B., Haltmeier M., Klingenhoff A., Frisch M., Bayerlein M., and Werner T. MatInspector and beyond: promoter analysis based on transcription factor binding sites. Bioinformatics 21 (2005) 2933-2942
19. Ray R., Snyder R.C., Thomas S., Koller C.A., and Miller D.M. Mithramycin blocks protein binding and function of the SV40 early promoter. J. Clin. Invest. 83 (1989) 2003-2007
20. Blume S.W., Snyder R.C., Ray R., Thomas S., Koller C.A., and Miller D.M. Mithramycin inhibits SP1 binding and selectively inhibits transcriptional activity of the dihydrofolate reductase gene in vitro and in vivo. J. Clin Invest. 88 (1991) 1613-1621
21. Esteller M. CpG island hypermethylation and tumor suppressor genes: a booming present, a brighter future. Oncogene 12 (2002) 5240-5247
22. Yu J., Wei M., Boyd Z., Lehmann E.B., Trotta R., Mao H., Liu S., Becknell B., Jaung M.S., Jarjoura D., Marcucci G., Wu L.C., and Caligiuri M.A. Transcriptional control of human T-BET expression: the role of Sp1. Eur. J. Immunol. 37 (2007) 2549-2561
23. Wasiluk K.R., McCulloch K.A., Banton K.L., and Dunn D.L. Sp1 elements regulate transcriptional activity within the murine Toll-like receptor 4 promoter. Surg. Infect. (Larchmt) 7 (2006) 489-499
24. Black A.R., Black J.D., and Azizkhan-Clifford J. Sp1 and kruppel-like factor family of transcription factors in cell growth regulation and cancer. J. Cell Physiol. 188 (2001) 143-160
25. Huether A., Hopfner M., Baradari V., Schuppan D., and Scherubl H. EGFR blockade by cetuximab alone or as combination therapy for growth control of hepatocellular cancer. Biochem. Pharmacol. 70 (2005) 1568-1578
26. Eger A., Aigner K., Sonderegger S., Dampier B., Oehler S., Schreiber M., Berx G., Cano A., Beug H., and Foisner R. DeltaEF1 is a transcriptional repressor of E-cadherin and regulates epithelial plasticity in breast cancer cells. Oncogene 24 (2005) 2375-2385
27. Aigner K., Dampier B., Descovich L., Mikula M., Sultan A., Schreiber M., Mikulits W., Brabletz T., Strand D., Obrist P., Sommergruber W., Schweifer N., Wernitznig A., Beug H., Foisner R., and Eger A. The transcription factor ZEB1 (deltaEF1) promotes tumour cell dedifferentiation by repressing master regulators of epithelial polarity. Oncogene 26 (2007) 6979-6988